RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Lotus Pharmaceutical Co Stock

Lotus Pharmaceutical Co P/E 2024

Lotus Pharmaceutical Co P/E

15.24

Ticker

1795.TW

ISIN

TW0001795003

As of Sep 29, 2024, Lotus Pharmaceutical Co's P/E ratio was 15.24, a -25.37% change from the 20.42 P/E ratio recorded in the previous year.

The Lotus Pharmaceutical Co P/E history

Lotus Pharmaceutical Co Aktienanalyse

What does Lotus Pharmaceutical Co do?

The Lotus Pharmaceutical Co. Ltd is a leading pharmaceutical conglomerate based in Taiwan. The company was founded in 1964 and has since become one of the most significant manufacturers of pharmaceutical products in Asia. In recent years, Lotus Pharm has undergone a strategic expansion into international markets and is now present in other countries such as Europe and the USA with its innovative products. The company's business model includes the manufacturing and distribution of pharmaceuticals, medical devices, and dietary supplements. The company relies on close collaboration with partners from the science and research sectors to constantly develop innovative products. The core divisions include Cardiovascular, Endocrinology, Gastroenterology, Immunology, Infectious Diseases, Neurology, Oncology, and Respiratory. In the Cardiovascular division, Lotus Pharm offers a range of products for the treatment of cardiovascular diseases. These include medications for lowering blood pressure, lowering cholesterol levels, and preventing blood clots. The Endocrinology division, on the other hand, provides medications for treating hormonal disorders and metabolic diseases. Examples of these are medications for treating diabetes or thyroid diseases. The Gastroenterology division includes products for the treatment of stomach and intestinal diseases, including medications for reflux, stomach problems, or digestive disorders. Immunology deals with medications for treating autoimmune diseases and allergic conditions, while Infectious Diseases offers medications for infectious diseases. Neurology, on the other hand, includes medications for the treatment of neurological diseases such as pain, migraines, epilepsy, or Alzheimer's. Another important area is Oncology, in which Lotus Pharm offers products for the treatment of cancer. In recent years, the company has introduced numerous innovative medications to the market, which can improve survival rates and enhance the quality of life for cancer patients. Lotus Pharm's product range also includes a range of dietary supplements that are intended to provide the body with essential nutrients and contribute to maintaining health and well-being. Lotus Pharm's products are manufactured in modern production facilities that adhere to the highest quality standards. To meet these high standards, the company relies on continuous monitoring of the manufacturing processes and strict quality assurance. Another crucial factor for the success of Lotus Pharm is its close collaboration with partners from the science and research sectors. The company works closely with leading scientists and researchers to continually gain new insights and promote innovation. In recent years, the company has also expanded into the international market and is now represented in Europe and the USA with its products. This demonstrates that Lotus Pharm's products are in high demand outside of Asia and enjoy international recognition. Overall, it can be said that Lotus Pharmaceutical Co. Ltd is a leading company in the pharmaceutical industry. The close collaboration with researchers and partners, the high quality of the products, and the constant innovation make the company a significant player in the industry. Lotus Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Lotus Pharmaceutical Co's P/E Ratio

The Price to Earnings (P/E) Ratio of Lotus Pharmaceutical Co is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Lotus Pharmaceutical Co's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Lotus Pharmaceutical Co is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Lotus Pharmaceutical Co’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Lotus Pharmaceutical Co stock

What is the price-to-earnings ratio of Lotus Pharmaceutical Co?

The price-earnings ratio of Lotus Pharmaceutical Co is currently 15.24.

How has the price-earnings ratio of Lotus Pharmaceutical Co changed compared to last year?

The price-to-earnings ratio of Lotus Pharmaceutical Co has increased by -25.37% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Lotus Pharmaceutical Co high compared to other companies?

Yes, the price-to-earnings ratio of Lotus Pharmaceutical Co is high compared to other companies.

How does an increase in the price-earnings ratio of Lotus Pharmaceutical Co affect the company?

An increase in the price-earnings ratio of Lotus Pharmaceutical Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Lotus Pharmaceutical Co affect the company?

A decrease in the price-earnings ratio of Lotus Pharmaceutical Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Lotus Pharmaceutical Co?

Some factors that influence the price-earnings ratio of Lotus Pharmaceutical Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Lotus Pharmaceutical Co pay?

Over the past 12 months, Lotus Pharmaceutical Co paid a dividend of 3.46 TWD . This corresponds to a dividend yield of about 1.28 %. For the coming 12 months, Lotus Pharmaceutical Co is expected to pay a dividend of 4.11 TWD.

What is the dividend yield of Lotus Pharmaceutical Co?

The current dividend yield of Lotus Pharmaceutical Co is 1.28 %.

When does Lotus Pharmaceutical Co pay dividends?

Lotus Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of August, September, August, September.

How secure is the dividend of Lotus Pharmaceutical Co?

Lotus Pharmaceutical Co paid dividends every year for the past 6 years.

What is the dividend of Lotus Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 4.11 TWD are expected. This corresponds to a dividend yield of 1.52 %.

In which sector is Lotus Pharmaceutical Co located?

Lotus Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lotus Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lotus Pharmaceutical Co from 8/30/2024 amounting to 4.647 TWD, you needed to have the stock in your portfolio before the ex-date on 8/5/2024.

When did Lotus Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 8/30/2024.

What was the dividend of Lotus Pharmaceutical Co in the year 2023?

In the year 2023, Lotus Pharmaceutical Co distributed 1.931 TWD as dividends.

In which currency does Lotus Pharmaceutical Co pay out the dividend?

The dividends of Lotus Pharmaceutical Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lotus Pharmaceutical Co

Our stock analysis for Lotus Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lotus Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.